LONDON, June 25 /PRNewswire/ --

- Quark Pharmaceuticals to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation

Silence Therapeutics plc (London AIM: SLN) today announces that the U.S. Food and Drug Administration (FDA) has approved a Quark Pharmaceuticals Inc ("Quark") Investigational New Drug application (IND) for an siRNA therapeutic product based on Silence's unique proprietary chemistry. The product, DGFi, was discovered and is being developed by Quark for use in kidney transplantation. Rights to the AtuRNAi structure of DGFi were licensed to Quark by Silence Therapeutics.

Energy from the sun and carbon dioxide fuel photosynthesis in plants and algae, making life on earth possible. Carbon that is fixed by plants is converted to starch and sucrose, which are utilized by plants for energy and to build biomass.

Human evolution and society have been intimately tied to our exploitation of plant biomass for food, fuel, tools, and shelter. However, to be usable, the starch carbohydrate stored in plants must be broken down to component sugars. Some aspects of starch metabolism have been known for many years, but regulation of the process and exact physical mechanisms are still not well understood.

With new information emerging from genome sequencing and mutational analyses, we are beginning to gain a better understanding of these complex and finely tuned processes. Such knowledge is especially critical as we struggle with issues of energy and food supply.

ANN ARBOR, Michigan, June 25 /PRNewswire/ --

Terumo Heart, Inc. announced today approval from the Institutional Review Board (IRB) at the University of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT) indication. Francis Pagani, M.D., Ph.D., Director of the Adult Heart Transplantation and Artificial Devices Program at the University of Michigan, will serve as the National Co-Principal Investigator of the U.S. Pivotal Trial.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )

REHOVOT, Israel and JERSEY CITY, New Jersey, June 25 /PRNewswire/ --

- Collaboration to Focus on the Development of MicroRNA-Based Tests for Oncology and Women's Health Indications

Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a collaboration with the Rabin Medical Center in Israel to develop microRNA-based diagnostics in the fields of oncology, gynecology, and obstetrics. The collaboration will leverage microRNAs' significant potential as highly sensitive and specific biomarkers, to develop a wide range of diagnostic and prognostic tests. This is the company's first collaboration to include a focus on diagnostics for women's health indications.

LONDON, June 25 /PRNewswire/ --

- Arxan Technologies Expands Global Footprint to Europe to Address Software Piracy and Tampering

An international team of researchers says they have evidence of explosive volcanism in the deeps of the ice-covered Arctic Ocean for the first time.

Researchers from an expedition to the Gakkel Ridge report in the current issue of Nature that they discovered extensive layers of volcanic ash on the seafloor, which indicates a gigantic volcanic eruption.

A major part of Earth's volcanism happens at the so-called mid-ocean ridges and, therefore, completely undetected on the seafloor. There, the continental plates drift apart; liquid magma intrudes into the gap and constantly forms new seafloor through countless volcanic eruptions. Accompanied by smaller earthquakes, which go unregistered on land, lava flows onto the seafloor. These unspectacular eruptions usually last for only a few days or weeks.

MOUNTAIN VIEW, California, June 25 /PRNewswire/ --

- Demonstrates Viability of Using Mobile TV Broadcasts for positioning-based Services

LONDON, June 25 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the digital 'front door' to the NHS releases a new, improved, guide aimed to help men aged 18-39 live healthier lifestyles.

Based on NHS accredited information, the online 'magazine' (http://www.nhs.uk/livewell/men1839/Pages/Men1839.aspx) enables users to find information on a wide range of topics ranging from how to protect against STIs and the importance of losing weight to how to quit smoking and drink in moderation. It includes clinically approved guidance to help people maintain a healthy lifestyle and is the latest addition to the NHS Choices' extensive Live Well section.

NEW YORK, June 25 /PRNewswire/ --

Today, the Board of Directors of WITNESS (www.witness.org), the international human rights organization co-founded by musician and activist Peter Gabriel, announced the appointment of Yvette J. Alberdingk Thijm as Executive Director.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080625/NYW021)

LONDON, June 25 /PRNewswire/ -- Staff working for CE Electric will begin industrial action this Thursday (26th June). The workers at Northern Electric Distribution Limited and Yorkshire Electricity Distribution which is owned by CE Electric will begin a continuous overtime ban and withdraw standby cover indefinitely unless a dispute over pay can be resolved.